These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 14742906)

  • 1. Overexpression of human cystatin C in transgenic mice does not affect levels of endogenous brain amyloid Beta Peptide.
    Pawlik M; Sastre M; Calero M; Mathews PM; Schmidt SD; Nixon RA; Levy E
    J Mol Neurosci; 2004; 22(1-2):13-8. PubMed ID: 14742906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation.
    Sastre M; Calero M; Pawlik M; Mathews PM; Kumar A; Danilov V; Schmidt SD; Nixon RA; Frangione B; Levy E
    Neurobiol Aging; 2004 Sep; 25(8):1033-43. PubMed ID: 15212828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients.
    Levy E; Sastre M; Kumar A; Gallo G; Piccardo P; Ghetti B; Tagliavini F
    J Neuropathol Exp Neurol; 2001 Jan; 60(1):94-104. PubMed ID: 11202179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
    Mi W; Pawlik M; Sastre M; Jung SS; Radvinsky DS; Klein AM; Sommer J; Schmidt SD; Nixon RA; Mathews PM; Levy E
    Nat Genet; 2007 Dec; 39(12):1440-2. PubMed ID: 18026100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques.
    Steinhoff T; Moritz E; Wollmer MA; Mohajeri MH; Kins S; Nitsch RM
    Neurobiol Dis; 2001 Aug; 8(4):647-54. PubMed ID: 11493029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C modulates cerebral beta-amyloidosis.
    Kaeser SA; Herzig MC; Coomaraswamy J; Kilger E; Selenica ML; Winkler DT; Staufenbiel M; Levy E; Grubb A; Jucker M
    Nat Genet; 2007 Dec; 39(12):1437-9. PubMed ID: 18026102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
    Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
    J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin B degrades amyloid-β in mice expressing wild-type human amyloid precursor protein.
    Wang C; Sun B; Zhou Y; Grubb A; Gan L
    J Biol Chem; 2012 Nov; 287(47):39834-41. PubMed ID: 23024364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ.
    Philipson O; Lord A; Lalowski M; Soliymani R; Baumann M; Thyberg J; Bogdanovic N; Olofsson T; Tjernberg LO; Ingelsson M; Lannfelt L; Kalimo H; Nilsson LN
    Neurobiol Aging; 2012 May; 33(5):1010.e1-13. PubMed ID: 22118948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine Aβ over-production produces diffuse and compact Alzheimer-type amyloid deposits.
    Xu G; Ran Y; Fromholt SE; Fu C; Yachnis AT; Golde TE; Borchelt DR
    Acta Neuropathol Commun; 2015 Nov; 3():72. PubMed ID: 26566997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease.
    Sun B; Zhou Y; Halabisky B; Lo I; Cho SH; Mueller-Steiner S; Devidze N; Wang X; Grubb A; Gan L
    Neuron; 2008 Oct; 60(2):247-57. PubMed ID: 18957217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
    Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
    Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
    Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin).
    Choi SH; Leight SN; Lee VM; Li T; Wong PC; Johnson JA; Saraiva MJ; Sisodia SS
    J Neurosci; 2007 Jun; 27(26):7006-10. PubMed ID: 17596449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
    Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of amyloid in the pathogenesis of Alzheimer's disease.
    Verbeek MM; Ruiter DJ; de Waal RM
    Biol Chem; 1997 Sep; 378(9):937-50. PubMed ID: 9348103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo.
    Lee EB; Zhang B; Liu K; Greenbaum EA; Doms RW; Trojanowski JQ; Lee VM
    J Cell Biol; 2005 Jan; 168(2):291-302. PubMed ID: 15642747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.